DexCom Total Liabilities and Share Holders Equity 2010-2024 | DXCM

DexCom total liabilities and share holders equity from 2010 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
  • DexCom total liabilities and share holders equity for the quarter ending September 30, 2024 was $6.354B, a 3.67% decline year-over-year.
  • DexCom total liabilities and share holders equity for 2023 was $6.265B, a 16.19% increase from 2022.
  • DexCom total liabilities and share holders equity for 2022 was $5.392B, a 9.29% increase from 2021.
  • DexCom total liabilities and share holders equity for 2021 was $4.933B, a 14.98% increase from 2020.
DexCom Annual Total Liabilities and Share Holders Equity
(Millions of US $)
2023 $6,265
2022 $5,392
2021 $4,933
2020 $4,291
2019 $2,395
2018 $1,916
2017 $904
2016 $403
2015 $292
2014 $185
2013 $123
2012 $106
2011 $121
2010 $77
2009 $47
DexCom Quarterly Total Liabilities and Share Holders Equity
(Millions of US $)
2024-09-30 $6,354
2024-06-30 $6,799
2024-03-31 $6,482
2023-12-31 $6,265
2023-09-30 $6,596
2023-06-30 $6,821
2023-03-31 $5,516
2022-12-31 $5,392
2022-09-30 $4,899
2022-06-30 $5,217
2022-03-31 $5,057
2021-12-31 $4,933
2021-09-30 $4,776
2021-06-30 $4,504
2021-03-31 $4,390
2020-12-31 $4,291
2020-09-30 $3,833
2020-06-30 $3,522
2020-03-31 $2,448
2019-12-31 $2,395
2019-09-30 $2,186
2019-06-30 $2,066
2019-03-31 $1,974
2018-12-31 $1,916
2018-09-30 $1,114
2018-06-30 $1,008
2018-03-31 $897
2017-12-31 $904
2017-09-30 $843
2017-06-30 $796
2017-03-31 $467
2016-12-31 $403
2016-09-30 $362
2016-06-30 $333
2016-03-31 $299
2015-12-31 $292
2015-09-30 $257
2015-06-30 $218
2015-03-31 $189
2014-12-31 $185
2014-09-30 $159
2014-06-30 $140
2014-03-31 $125
2013-12-31 $123
2013-09-30 $110
2013-06-30 $102
2013-03-31 $99
2012-12-31 $106
2012-09-30 $103
2012-06-30 $111
2012-03-31 $118
2011-12-31 $121
2011-09-30 $129
2011-06-30 $136
2011-03-31 $67
2010-12-31 $77
2010-09-30 $54
2010-06-30 $61
2010-03-31 $68
2009-12-31 $47
2009-09-30 $54
2009-06-30 $65
2009-03-31 $78
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $29.084B $3.622B
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems (CGM). These are for ambulatory use by people with diabetes and by healthcare providers for the treatment of diabetic and non-diabetic patients. A key element of DexCom's monitoring system technology is the continuous measure of patient's blood glucose level and transmission of that information to a small cell phone-sized receiver in real time. The company's monitoring systems aim to provide real-time continuous blood glucose values, trend data and alerts to assist patients in managing their blood glucose levels.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $197.408B 24.08
Intuitive Surgical (ISRG) United States $196.120B 102.54
Alcon (ALC) Switzerland $42.207B 28.24
Edwards Lifesciences (EW) United States $41.510B 26.36
IQVIA Holdings (IQV) United States $35.864B 19.76
IDEXX Laboratories (IDXX) United States $34.273B 40.36
Waters (WAT) United States $21.880B 32.35
STERIS (STE) Ireland $21.298B 24.52
SONOVA HOLDING (SONVY) Switzerland $20.458B 0.00
Hologic (HOLX) United States $18.284B 19.29
Fresenius Medical Care AG KGaA (FMS) Germany $12.898B 13.24
Sysmex ADR (SSMXY) Japan $12.776B 40.07
Globus Medical (GMED) United States $11.562B 29.28
Penumbra (PEN) United States $9.230B 90.41
Masimo (MASI) United States $9.055B 43.81
Teleflex (TFX) United States $8.854B 14.12
Glaukos (GKOS) United States $7.765B 0.00
PROCEPT BioRobotics (PRCT) United States $4.929B 0.00
Integer Holdings (ITGR) United States $4.558B 25.83
Veracyte (VCYT) United States $3.018B 90.56
Inari Medical (NARI) United States $2.913B 0.00
LivaNova (LIVN) United Kingdom $2.807B 16.21
TransMedics (TMDX) United States $2.663B 84.40
Nihon Kohden (NHNKY) Japan $2.428B 18.44
Elekta AB (EKTAY) Sweden $2.125B 17.31
Tandem Diabetes Care (TNDM) United States $2.019B 0.00
RxSight (RXST) United States $1.816B 0.00
Integra LifeSciences Holdings (IART) United States $1.775B 9.27
Alphatec Holdings (ATEC) United States $1.448B 0.00
Artivion (AORT) United States $1.175B 77.86
OPKO Health (OPK) United States $1.065B 0.00
Pulse Biosciences (PLSE) United States $0.992B 0.00
Paragon 28 (FNA) United States $0.873B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.828B 14.08
ORTHOFIX MEDICAL INC (OFIX) United States $0.714B 0.00
IRadimed (IRMD) United States $0.675B 36.46
OrthoPediatrics (KIDS) United States $0.641B 0.00
AxoGen (AXGN) United States $0.577B 0.00
Mesa Laboratories (MLAB) United States $0.548B 12.91
SiBone (SIBN) United States $0.515B 0.00
Treace Medical Concepts (TMCI) United States $0.495B 0.00
Pacific Biosciences Of California (PACB) United States $0.485B 0.00
Semler Scientific (SMLR) United States $0.483B 32.40
Tactile Systems Technology (TCMD) United States $0.383B 20.70
CVRx (CVRX) United States $0.358B 0.00
Delcath Systems (DCTH) United States $0.315B 0.00
ClearPoint Neuro (CLPT) United States $0.306B 0.00
AngioDynamics (ANGO) United States $0.282B 0.00
NeuroPace (NPCE) United States $0.269B 0.00
Inogen (INGN) United States $0.219B 0.00
Sight Sciences (SGHT) United States $0.191B 0.00
Accuray (ARAY) United States $0.190B 0.00
KORU Medical Systems (KRMD) United States $0.164B 0.00
Nevro (NVRO) United States $0.163B 0.00
Alpha Tau Medical (DRTS) Israel $0.160B 0.00
Atossa Genetics (ATOS) United States $0.150B 0.00
Sensus Healthcare (SRTS) United States $0.146B 15.67
Spectral Diagnostics (EDTXF) Canada $0.105B 0.00
908 Devices (MASS) United States $0.095B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.087B 0.00
WORK Medical Technology Group (WOK) China $0.084B 0.00
Covalon Technologies (CVALF) Canada $0.077B 0.00
Hyperfine (HYPR) United States $0.071B 0.00
Monogram Orthopaedics (MGRM) United States $0.068B 0.00
InspireMD (NSPR) Israel $0.067B 0.00
Vicarious Surgical (RBOT) United States $0.061B 0.00
Lucid Diagnostics (LUCD) United States $0.059B 0.00
EnVVeno Medical (NVNO) United States $0.058B 0.00
Rapid Micro Biosystems (RPID) United States $0.048B 0.00
Envoy Medical (COCH) United States $0.045B 0.00
Accelerate Diagnostics (AXDX) United States $0.042B 0.00
Adagio Medical Holdings (ADGM) United States $0.033B 0.00
Biosig Technologies (BSGM) United States $0.033B 0.00
Precision Optics (POCI) United States $0.032B 0.00
DarioHealth (DRIO) United States $0.028B 0.00
Neuronetics (STIM) United States $0.025B 0.00
NexGel (NXGL) United States $0.022B 0.00
Spectral AI (MDAI) United States $0.021B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Ekso Bionics Holdings (EKSO) United States $0.016B 0.00
Microbot Medical (MBOT) United States $0.016B 0.00
Autonomix Medical (AMIX) United States $0.016B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Aspira Women's Health (AWH) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.011B 0.00
PAVmed (PAVM) United States $0.011B 0.00
T2 Biosystems (TTOO) United States $0.009B 0.00
Tenon Medical (TNON) United States $0.008B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.006B 0.00
Nuwellis (NUWE) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00